Accueil › Leucémie aiguë myéloïde › Oregon › Portland
Essais cliniques pour Leucémie aiguë myéloïde à Portland, OR
25 études pour Leucémie aiguë myéloïde recherchent des participants dans et autour de Portland (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Recrutement en coursPhase 2
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
Ruxolitinib With Azacitidine Maintenance for the Treatment of Patients With Acute Myeloid Leukemia Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation
Recrutement en coursPhase 1
- OHSU Knight Cancer Institute, Portland
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Recrutement en coursÉtude observationnelleVolontaires sains bienvenus
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Providence Willamette Falls Medical Center, Oregon City · à 12 mi
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Recrutement en coursPhase 2
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
Recrutement en coursPhase 3
- Providence Portland Medical Center, Portland
- Providence Oncology and Hematology Care Clinic Westside, Portland
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Recrutement en coursPhase 1
- OHSU Knight Cancer Institute, Portland
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Recrutement en coursPhase 2
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Recrutement en coursPhase 2
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Recrutement en coursPhase 3
- Legacy Emanuel Children's Hospital, Portland
- Oregon Health and Science University, Portland
Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine Plus Venetoclax for the Treatment of Newly Diagnosed Monocytic AML and Active Signaling Mutated AML
Recrutement en coursPhase 2
- OHSU Knight Cancer Institute, Portland
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
Recrutement en coursPhase 1/2
- Oregon Health & Science University, Portland
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
Recrutement en coursPhase 1/2
- Oregon Health and Science University, Portland
Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML
Recrutement en coursPhase 3
- US-Portland OR-OHSU, Portland
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Recrutement en coursPhase 1/2
- Legacy Emanuel Children's Hospital, Portland
- Oregon Health and Science University, Portland
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Recrutement en coursPhase 3
- Doernbecher Children's Hospital, Portland
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
Recrutement en coursPhase 3
- Oregon Health & Science University (OHSU) - Knight Cancer Institute, Portland
Pemigatinib After Chemotherapy for the Treatment of Newly Diagnosed Acute Myeloid Leukemia
Recrutement en coursPhase 1
- OHSU Knight Cancer Institute, Portland
Induction and Consolidation With Fludarabine, Cytarabine, Idarubicin, and Venetoclax for the Treatment of Acute Myeloid Leukemia
Recrutement en coursPhase 2
- OHSU Knight Cancer Institute, Portland
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Recrutement en coursPhase 2
- Oregon Health and Science University, Portland
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Recrutement en coursÉtude observationnelle
- Oregon Health & Science University/Doernbecher Children's Hospital, Portland
Iadademstat in Combination With Azacitidine and Venetoclax in Treating Newly Diagnosed Acute Myeloid Leukemia
Recrutement en coursPhase 1
- OHSU Knight Cancer Institute, Portland
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Recrutement en coursPhase 2/3
- Oregon Health and Science University, Portland
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Recrutement en coursPhase 2
- Oregon Health & Science University, Portland
A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)
Recrutement en coursPhase 1
- OHSU, Portland
Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia
Recrutement en coursVolontaires sains bienvenus
- Oregon Health & Science University, Portland
Essais pour Leucémie aiguë myéloïde dans d'autres villes
- Houston, TX85 études
- New York City, NY51 études
- Boston, MA44 études
- Seattle, WA41 études
- Baldwin Park, CA40 études
- Columbus, OH35 études
- Philadelphia, PA34 études
- Durham, NC33 études
- Atlanta, GA31 études
- Tampa, FL29 études
- Chicago, IL26 études
- Washington, DC24 études
Autres études à Portland
- Cancer du poumon non à petites cellules46 études
- Cancer (tous types)34 études
- Cancer du sein33 études
- Cancer de la prostate33 études
- Cancer métastatique29 études
- Cancer colorectal28 études
- Cancer de l'ovaire27 études
- Cancer du poumon26 études
- Cancer de l'endomètre24 études
- Carcinome épidermoïde de la tête et du cou19 études
- Cancer du pancréas19 études
- Insuffisance cardiaque17 études
Source : ClinicalTrials.gov, données récupérées le 6 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.